PARRY-ROMBERG SYNDROME: CAUSES, SYMPTOMS, AND TREATMENT OF PROGRESSIVE FACIAL HEMIATROPHY

Medically Reviewed by Dr. Sony Sherpa (MBBS)

Parry-Romberg Syndrome (PRS) is an acquired, progressive disorder characterized by hemifacial atrophy, where the soft tissues, and in some cases the underlying bones, on one side of the face undergo gradual shrinkage. This rare condition may occasionally involve both sides in extremely rare cases. PRS typically begins in childhood or adolescence and progresses slowly over several years before stabilizing.

The exact prevalence of PRS remains unknown due to its rarity, but it is recognized as a rare disorder with sporadic occurrence. The condition poses significant challenges in both diagnosis and treatment, as its early symptoms are subtle and non-specific, often leading to delays in identification. Furthermore, there is no definitive cure for PRS, and treatment primarily focuses on managing its symptoms, addressing functional impairments, and providing cosmetic reconstruction to improve quality of life.

Understanding Parry-Romberg Syndrome

Parry-Romberg Syndrome (PRS) is primarily characterized by the progressive shrinkage (atrophy) of soft tissues, including skin, fat, and muscles, on one side of the face. In some cases, the underlying bones may also be affected, leading to more pronounced asymmetry. This atrophy typically starts in the middle of the face and may extend to the upper lip, nose, and areas around the eye, eventually impacting the neck, tongue, and even the gums and roof of the mouth in advanced cases.

The condition predominantly affects one side of the face (hemifacial), with bilateral involvement being extremely rare. The progression of the syndrome is highly variable; while some individuals may experience mild asymmetry with little functional impact, others may face significant facial changes that interfere with essential functions such as eating, speaking, and vision.

What is the Cause of Parry-Romberg Syndrome?

The exact cause of Parry-Romberg Syndrome (PRS) remains unknown, making it a subject of ongoing research and speculation. Several theories have been proposed to explain its development:

• Autoimmune Disorders: One prevailing theory suggests that PRS may have an autoimmune etiology characterized by the immune system inappropriately targeting the body's own soft tissues and their supporting structures.
• Vascular Abnormalities: Some researchers believe that localized vascular problems, such as blood vessel inflammation or disruptions in blood supply, could contribute to the atrophy seen in PRS.
• Localized Scleroderma (En Coup De Sabre): PRS is often associated with linear scleroderma, a condition characterized by hardening and thickening of the skin. This connection has led to speculation that the two conditions might share a common pathological mechanism, although the exact relationship remains unclear.

Despite these theories, no definitive cause has been identified, and PRS is generally considered a multifactorial disorder with possible genetic, environmental, and immunological influences.

Risk Factors for Parry-Romberg Syndrome

PRS is a sporadic condition with no clearly established risk factors. It affects both sexes, though it is slightly more common in females. Most cases appear to arise without a family history of similar disorders, suggesting that genetic predisposition may play a minimal role.

The condition often begins in childhood or adolescence, and while no environmental or lifestyle factors have been directly linked, the possible autoimmune and vascular underpinnings point to complex, multifaceted triggers.

Parry-Romberg Syndrome Symptoms and Complications

Parry-Romberg Syndrome (PRS) is characterized by a range of symptoms, primarily involving progressive facial atrophy and other systemic manifestations.

Early Symptoms

• The onset of PRS is gradual, typically beginning in childhood or adolescence.
• Facial asymmetry starts subtly, with progressive shrinkage of soft tissues on one side of the face, which may worsen over several years before stabilizing.
• The middle of the face is most commonly affected, including the upper lip, the area below the nose, and regions around the eye and ear.
• Advanced cases may involve atrophy of the neck, tongue, gums, and roof of the mouth.

Neurological Symptoms

• Headaches: Persistent or episodic headaches, including migraines, are common in PRS patients.
• Seizures: Some individuals develop seizures, often related to cortical atrophy or brain abnormalities visible in imaging studies.
• Trigeminal Neuralgia: Severe, sharp facial pain along the trigeminal nerve pathway may occur.
• Hearing Loss: Involvement of tissues around the ear or the auditory canal may impair hearing on the affected side.

Ophthalmologic Manifestations

• Drooping of the eyelid (ptosis).
• Enophthalmos, where the eye appears sunken due to tissue loss.
• Visual disturbances caused by changes in orbital structure or nearby tissues.

Orthodontic Changes

• Misalignment of teeth due to asymmetry in jaw growth. Misaligned teeth and jaw deformities may require extensive corrective measures.
• Structural abnormalities affecting the upper jaw, gums, and roof of the mouth. Atrophy of the tongue, gums, and oral tissues can interfere with articulation, making speech difficult. Similarly, jaw asymmetry, dental misalignment, and tissue loss in the mouth may make chewing and swallowing challenging. 

Other Features

• Systemic Anomalies: Rarely, PRS may involve other areas of the body, such as the arm, trunk, or leg on the same side, leading to localized muscle or bone anomalies.
• Hair Abnormalities: Patches of hair loss (alopecia) or whitening of hair in affected areas.
• Skin Changes: Abnormal darkening of the skin (hyperpigmentation) or depigmented patches resembling vitiligo, or thinning of the skin can increase vulnerability to injury or infection in affected areas.

Psychological and Emotional Impact

• Self-esteem Issues: Visible facial changes can significantly affect self-image and confidence.
• Social Anxiety and Isolation: The asymmetry and visible differences may lead to discomfort in social settings.
• Depression: The chronic nature of the condition and its cosmetic and functional effects can contribute to mental health struggles.

Parry-Romberg Syndrome and Linear Scleroderma

What is Linear Scleroderma?

Linear scleroderma is a localized form of scleroderma, a connective tissue disorder characterized by thickening and hardening of the skin. In linear scleroderma, these changes appear as a band or streak, often resembling a scar, and can occur on the face, scalp, or body.

A distinctive subtype of linear scleroderma, known as “en coup de sabre” (French for "stroke of the sword"), manifests as a linear depression on the forehead or scalp. This feature is often associated with Parry-Romberg Syndrome (PRS), and the two conditions commonly co-occur.

While the exact relationship between PRS and linear scleroderma remains unclear, some researchers speculate that both may share underlying mechanisms, such as autoimmune dysregulation or vascular abnormalities. However, it is uncertain whether one condition directly causes the other or if they are separate entities that overlap in presentation.

Diagnosis of Parry-Romberg Syndrome

Diagnosing Parry-Romberg Syndrome is challenging due to its rarity and the subtle, non-specific nature of its early symptoms. The lack of definitive diagnostic criteria further complicates the process.

Steps in Diagnosis

• Physical Examination:
  • A thorough evaluation of facial asymmetry and other signs of atrophy.
  • Identification of associated features, such as skin changes, ophthalmologic issues, or neurological symptoms.
• Detailed Medical History:
  • Assessment of symptom onset and progression.
  • Investigation of any family history of autoimmune or connective tissue disorders.
• Imaging Studies:
  • MRI (Magnetic Resonance Imaging): Useful for identifying structural changes in soft tissues, bones, and brain abnormalities, such as cortical atrophy or white matter lesions.
  • CT (Computed Tomography) Scan: Helps evaluate bone involvement and asymmetry.
• Laboratory Tests:
  • This may be conducted to rule out other autoimmune or connective tissue disorders, as there is no specific test to definitively diagnose PRS.

Treatment and Management

Acknowledging the Lack of a Cure

Parry-Romberg Syndrome (PRS) currently has no cure. Treatment focuses on managing symptoms, improving functional abilities, and addressing cosmetic concerns. Since the condition's progression often stabilizes after several years, interventions are typically tailored to the individual's needs during and after the active phase of the disease.

Treatment Approaches

• Physical Therapy
  • Helps maintain facial muscle function and prevents further decline in muscle strength and coordination.
  • Aims to improve overall mobility and facial symmetry during daily activities.
• Medications
  • Corticosteroids: May be used to suppress inflammation and potentially slow tissue atrophy.
  • Immunosuppressive Medications: Drugs such as methotrexate or mycophenolate mofetil are sometimes prescribed, although evidence for their effectiveness is limited.
• Surgical Treatments
  • Facial Reconstruction:
    • Procedures aim to restore facial symmetry and improve appearance.
    • Techniques include fat grafting, silicone or other implants, microvascular surgery, and bone or muscle grafting.
  • Skin Flap Grafts: Used to replace lost skin and subcutaneous tissue, providing more natural contours.
  • Cosmetic Enhancements: Injections of fillers, such as hyaluronic acid, to address localized atrophy.
  • Surgical interventions are usually delayed until the disease has stabilized to ensure the best results.

Latest Advancements in Parry-Romberg Syndrome Research

Current research endeavors aim to elucidate the etiology of PRS and develop more effective treatment modalities.

• Stem Cell Therapy
  • Investigated as a potential treatment to regenerate soft tissues and halt disease progression.
  • Early studies suggest promising results in reducing atrophy and improving appearance, though long-term outcomes remain unclear.

To search for the best pediatric healthcare providers in Azerbaijan, Germany, India, Malaysia, Singapore, Spain, Thailand, Turkey, the UAE, the UK and The USA, please use the Mya Care Search engine.

To search for the best Plastic and Cosmetic Surgery healthcare providers in Croatia, Germany, Greece, India, Malaysia, Poland, Singapore, Slovakia, Spain, Thailand, Turkey, Ukraine, the UAE, and the UK, please use the Mya Care Search engine.

References:

Show All ▼

Disclaimer